Patent intelligence · Companies
Company patent strength
Non-educational filers ranked by their patent portfolio. Grant rate and lapsed share expose where high filing volume is not matched by granted patents. Domestic filers lead — toggle to foreign applicants to see who is entering the Indian market.
Free to browse the ranking. Sign into open a filer's full profile — inventors, filing trend and quality index. See how we rank.
Why this page exists — and how to read it
Filing volume and IP quality are different things. This leaderboard ranks non-educational filers by portfolio, but the grant-rate and lapsed sorts are where the judgement lives: they separate companies whose filings survive examination from those accumulating paper.
- Investors
- High grant rate on steady filing usually means a real R&D engine; big volume with a high lapsed share is a red flag worth asking about.
- Founders & operators
- These are the incumbents and potential acquirers in your space — open a filer to see the walls you'd build against.
- Corporate & R&D
- Benchmark competitors' portfolios and grant rates; toggle to foreign to watch who is entering the Indian market.
💬 The grant-rate sort applies a 20-filing floor so tiny portfolios can't top the list.
3,207 foreign filers with 5+ patents · page 51
| # | Filer | Patents↓ | Granted↓ | Lapsed↓ | Pending↓ | Active |
|---|---|---|---|---|---|---|
| 2501 | PROPHESEE | 6 | 00% | 0 | 6 | 2023–2024 |
| 2502 | PROVEPHARM LIFE SOLUTIONS | 6 | 00% | 0 | 6 | 2022–2024 |
| 2503 | PUREC | 6 | 116.7% | 0 | 5 | 2022–2026 |
| 2504 | PYC THERAPEUTICS | 6 | 00% | 0 | 6 | 2022–2025 |
| 2505 | QINGDAO HAIER REFRIGERATOR | 6 | 00% | 0 | 6 | 2022–2023 |
| 2506 | QUANTOOM BIOSCIENCES | 6 | 00% | 1 | 5 | 2024–2025 |
| 2507 | QURALIS | 6 | 00% | 0 | 6 | 2022–2026 |
| 2508 | RADEXEL | 6 | 00% | 0 | 6 | 2022–2025 |
| 2509 | RAIN CARBON GERMANY | 6 | 116.7% | 0 | 5 | 2022–2024 |
| 2510 | RAQUALIA PHARMA | 6 | 00% | 2 | 4 | 2022–2026 |
| 2511 | REDDRESS | 6 | 116.7% | 0 | 5 | 2022–2025 |
| 2512 | RELIANCE JIO INFOCOMM USA | 6 | 00% | 1 | 5 | 2023–2024 |
| 2513 | RENEWABLE ENERGY GROUP | 6 | 00% | 0 | 6 | 2024–2025 |
| 2514 | RENK | 6 | 00% | 1 | 5 | 2023–2026 |
| 2515 | REPT BATTERO ENERGY | 6 | 116.7% | 0 | 5 | 2022–2024 |
| 2516 | RIBON THERAPEUTICS | 6 | 350% | 0 | 3 | 2021–2024 |
| 2517 | ROCK BIOMEDICAL | 6 | 00% | 0 | 6 | 2025–2026 |
| 2518 | RONAWK | 6 | 00% | 0 | 6 | 2024–2025 |
| 2519 | RWE GENERATION NL | 6 | 00% | 0 | 6 | 2023–2023 |
| 2520 | SAINT GOBAIN WEBER | 6 | 350% | 0 | 3 | 2022–2022 |
| 2521 | SAIPEM | 6 | 116.7% | 0 | 5 | 2022–2026 |
| 2522 | SANAS AI | 6 | 6100% | 0 | 0 | 2023–2024 |
| 2523 | SANDHILL ONE | 6 | 00% | 1 | 5 | 2022–2024 |
| 2524 | SANDVIK ROCK PROCESSING AUSTRALIA PTY | 6 | 00% | 0 | 6 | 2023–2024 |
| 2525 | SANOTIZE RESEARCH AND DEVELOPMENT | 6 | 116.7% | 0 | 5 | 2022–2024 |
| 2526 | SANY RENEWABLE ENERGY | 6 | 00% | 0 | 6 | 2022–2024 |
| 2527 | SCHOCK | 6 | 116.7% | 0 | 5 | 2022–2024 |
| 2528 | SEMICONDUCTOR ENERGY LABORATORY | 6 | 00% | 0 | 6 | 2022–2026 |
| 2529 | SENSUS SPECTRUM | 6 | 233.3% | 0 | 4 | 2021–2025 |
| 2530 | SETTIMA MECCANICA S R L | 6 | 00% | 0 | 6 | 2022–2025 |
| 2531 | SGD | 6 | 466.7% | 0 | 2 | 2022–2023 |
| 2532 | SHANGHAI RUIPU ENERGY | 6 | 116.7% | 0 | 5 | 2022–2024 |
| 2533 | SHANGHAI SIMR BIOTECHNOLOGY | 6 | 233.3% | 0 | 4 | 2022–2024 |
| 2534 | SHENZHEN BLUETRUM TECHNOLOGY | 6 | 233.3% | 1 | 3 | 2022–2023 |
| 2535 | SHENZHEN FSJ INTELLIGENT TECHNICAL | 6 | 00% | 1 | 5 | 2024–2025 |
| 2536 | SHENZHEN KAIYAN MEDICAL EQUIPMENT | 6 | 116.7% | 1 | 4 | 2024–2025 |
| 2537 | SHENZHEN ROBOROCK INNOVATION TECHNOLOGY | 6 | 00% | 4 | 2 | 2025–2025 |
| 2538 | SHOCKWAVE MEDICAL | 6 | 00% | 0 | 6 | 2023–2025 |
| 2539 | SHUKLA MEDICAL | 6 | 466.7% | 0 | 2 | 2022–2024 |
| 2540 | SIEMENS ENERGY | 6 | 116.7% | 0 | 5 | 2022–2024 |
| 2541 | SK MICROWORKS | 6 | 116.7% | 0 | 5 | 2022–2025 |
| 2542 | SLOAN VALVE | 6 | 116.7% | 0 | 5 | 2020–2025 |
| 2543 | SMART SHOOTER | 6 | 00% | 0 | 6 | 2023–2024 |
| 2544 | SMARTSEAL AS | 6 | 00% | 0 | 6 | 2022–2025 |
| 2545 | SMITHS DETECTION FRANCE S | 6 | 00% | 0 | 6 | 2023–2026 |
| 2546 | SOCIETE BIC | 6 | 116.7% | 0 | 5 | 2022–2024 |
| 2547 | SOFTHALE | 6 | 00% | 0 | 6 | 2022–2023 |
| 2548 | SOLO BRANDS | 6 | 233.3% | 0 | 4 | 2022–2025 |
| 2549 | SOLUGEN | 6 | 00% | 0 | 6 | 2022–2024 |
| 2550 | SONY INTERACTIVE ENTERTAINMENT | 6 | 116.7% | 0 | 5 | 2020–2025 |
Educational institutes are excluded — see the institute leaderboard. Attribution is by patent assignee record; a jointly-owned patent is credited to each co-owner, so a co-filed patent counts for every company on it. "Lapsed" = abandoned, withdrawn, deemed-withdrawn or refused; "Pending" = awaiting examination or in prosecution. Want to filter by technology or value category? Browse the filer explorer →
Rankings use patent-registry status (grant rate, examination, claim depth) as a quality proxy — directional, not advice; see methodology. Read the ranking methodology →